Advertorial

rfC included in the new draft 5.1.10 by the European Pharmacopeia

Posted: 2 October 2014 | | No comments yet

News from the European Pharmacopoeia:

draft chapter

The new draft of chapter 5.1.10 published in Pharmeuropa 26.4 by the European Pharmacopoeia last Friday includes Recombinant Factor C (rFC) methods as well as the EndoLISA technology.

The text for comments can be obtained here >>

Deadline for comments is 31.12.2014.